KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is participating in a clinical research study evaluating a
new medication. Which statement by the nurse best describes
the primary purpose of a randomized controlled clinical trial
before a medication receives regulatory approval?
A. To compare the medication's safety and effectiveness with
appropriate controls while minimizing bias
B. To determine the medication's manufacturing cost before
marketing
C. To establish the medication's shelf life under all storage
conditions
D. To identify every possible adverse effect before the
medication is given to patients
Correct Answer: A
Rationale:
Randomized controlled clinical trials are designed to evaluate
the safety and effectiveness of a medication while reducing bias
through random assignment and the use of comparison groups.
Option B is incorrect because manufacturing cost is not the
purpose of clinical trials. Option C is incorrect because stability
testing is separate from efficacy trials. Option D is incorrect
,because rare adverse effects may not become apparent until
after widespread clinical use.
Question 2
A nurse is reviewing a medication order for a drug recently
approved for clinical use. Which situation best illustrates
pharmacovigilance after the medication reaches the market?
A. Reporting a previously unrecognized serious adverse reaction
through the appropriate monitoring system
B. Measuring the drug's chemical purity before packaging
C. Determining the drug's molecular structure during laboratory
development
D. Selecting laboratory animals for toxicity testing
Correct Answer: A
Rationale:
Pharmacovigilance involves ongoing monitoring and reporting
of adverse drug reactions after a medication is marketed. This
process helps identify uncommon or delayed adverse events.
Options B, C, and D occur during earlier stages of drug
development rather than post-marketing surveillance.
Question 3
A nurse explains to a patient that the prescribed medication is a
"generic drug." Which information is most appropriate?
, A. It contains the same active ingredient and is expected to
provide comparable therapeutic effects as the approved
reference product.
B. It is always manufactured by the company that developed
the original medication.
C. It has a different active ingredient but produces similar
effects.
D. It has fewer adverse effects than the brand-name
medication.
Correct Answer: A
Rationale:
Generic medications contain the same active ingredient, dosage
form, strength, route of administration, and are expected to
demonstrate comparable bioavailability and therapeutic effect
to the approved reference product. Option B is incorrect
because generic manufacturers are often different companies.
Option C is incorrect because different active ingredients
describe therapeutic alternatives, not generics. Option D is
incorrect because generics are not inherently associated with
fewer adverse effects.
Question 4
A nurse is caring for a patient enrolled in a clinical study. Which
action best demonstrates protection of the patient's rights?
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is participating in a clinical research study evaluating a
new medication. Which statement by the nurse best describes
the primary purpose of a randomized controlled clinical trial
before a medication receives regulatory approval?
A. To compare the medication's safety and effectiveness with
appropriate controls while minimizing bias
B. To determine the medication's manufacturing cost before
marketing
C. To establish the medication's shelf life under all storage
conditions
D. To identify every possible adverse effect before the
medication is given to patients
Correct Answer: A
Rationale:
Randomized controlled clinical trials are designed to evaluate
the safety and effectiveness of a medication while reducing bias
through random assignment and the use of comparison groups.
Option B is incorrect because manufacturing cost is not the
purpose of clinical trials. Option C is incorrect because stability
testing is separate from efficacy trials. Option D is incorrect
,because rare adverse effects may not become apparent until
after widespread clinical use.
Question 2
A nurse is reviewing a medication order for a drug recently
approved for clinical use. Which situation best illustrates
pharmacovigilance after the medication reaches the market?
A. Reporting a previously unrecognized serious adverse reaction
through the appropriate monitoring system
B. Measuring the drug's chemical purity before packaging
C. Determining the drug's molecular structure during laboratory
development
D. Selecting laboratory animals for toxicity testing
Correct Answer: A
Rationale:
Pharmacovigilance involves ongoing monitoring and reporting
of adverse drug reactions after a medication is marketed. This
process helps identify uncommon or delayed adverse events.
Options B, C, and D occur during earlier stages of drug
development rather than post-marketing surveillance.
Question 3
A nurse explains to a patient that the prescribed medication is a
"generic drug." Which information is most appropriate?
, A. It contains the same active ingredient and is expected to
provide comparable therapeutic effects as the approved
reference product.
B. It is always manufactured by the company that developed
the original medication.
C. It has a different active ingredient but produces similar
effects.
D. It has fewer adverse effects than the brand-name
medication.
Correct Answer: A
Rationale:
Generic medications contain the same active ingredient, dosage
form, strength, route of administration, and are expected to
demonstrate comparable bioavailability and therapeutic effect
to the approved reference product. Option B is incorrect
because generic manufacturers are often different companies.
Option C is incorrect because different active ingredients
describe therapeutic alternatives, not generics. Option D is
incorrect because generics are not inherently associated with
fewer adverse effects.
Question 4
A nurse is caring for a patient enrolled in a clinical study. Which
action best demonstrates protection of the patient's rights?
